Cellebrite DI (CLBT) Total Liabilities: 2020-2025

Historic Total Liabilities for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to $386.6 million.

  • Cellebrite DI's Total Liabilities rose 16.83% to $386.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 24.94%. This contributed to the annual value of $354.5 million for FY2024, which is 28.90% down from last year.
  • Latest data reveals that Cellebrite DI reported Total Liabilities of $386.6 million as of Q3 2025, which was up 2.01% from $379.0 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Total Liabilities high stood at $596.7 million for Q2 2024, and its period low was $293.0 million during Q3 2022.
  • Moreover, its 3-year median value for Total Liabilities was $386.6 million (2025), whereas its average is $424.5 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 107.21% in 2021, then tumbled by 37.68% in 2025.
  • Over the past 5 years, Cellebrite DI's Total Liabilities (Quarterly) stood at $413.1 million in 2021, then decreased by 20.26% to $329.4 million in 2022, then spiked by 51.38% to $498.7 million in 2023, then dropped by 28.90% to $354.5 million in 2024, then rose by 16.83% to $386.6 million in 2025.
  • Its Total Liabilities stands at $386.6 million for Q3 2025, versus $379.0 million for Q2 2025 and $346.4 million for Q1 2025.